Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis
Open Access
- 19 June 2012
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (9) , 1823-1829
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Towards a rational use of low-molecular-weight heparin in patients with cirrhosisLiver International, 2011
- The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patientsThrombosis Journal, 2011
- Low‐molecular‐weight heparin in patients with advanced cirrhosisLiver International, 2010
- X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)New England Journal of Medicine, 2009
- The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort studyJournal of Thrombosis and Haemostasis, 2005
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡Hepatology, 2005
- Haemostatic abnormalities in patients with liver diseaseJournal of Hepatology, 2002
- Abnormal Propeptide Processing Resulting in the Presence of Two Abnormal Species of Protein C in PlasmaThrombosis and Haemostasis, 2001
- State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same KindredClinical and Applied Thrombosis/Hemostasis, 2000
- Incidence of Venous Thromboembolism in Families with Inherited ThrombophiliaThrombosis and Haemostasis, 1999